546 related articles for article (PubMed ID: 34813820)
21. Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people.
Pinto Pereira SM; Nugawela MD; Rojas NK; Shafran R; McOwat K; Simmons R; Ford T; Heyman I; Ladhani SN; Cheung EY; Fox-Smith L; Dalrymple E; Stephenson T
Arch Dis Child; 2023 Apr; 108(4):289-295. PubMed ID: 36599625
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
Ma Y; Deng J; Liu Q; Du M; Liu M; Liu J
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674367
[TBL] [Abstract][Full Text] [Related]
25. Persistent symptoms among post-COVID-19 survivors: A systematic review and meta-analysis.
Rochmawati E; Iskandar AC; Kamilah F
J Clin Nurs; 2024 Jan; 33(1):29-39. PubMed ID: 36426658
[TBL] [Abstract][Full Text] [Related]
26. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.
Funk AL; Kuppermann N; Florin TA; Tancredi DJ; Xie J; Kim K; Finkelstein Y; Neuman MI; Salvadori MI; Yock-Corrales A; Breslin KA; Ambroggio L; Chaudhari PP; Bergmann KR; Gardiner MA; Nebhrajani JR; Campos C; Ahmad FA; Sartori LF; Navanandan N; Kannikeswaran N; Caperell K; Morris CR; Mintegi S; Gangoiti I; Sabhaney VJ; Plint AC; Klassen TP; Avva UR; Shah NP; Dixon AC; Lunoe MM; Becker SM; Rogers AJ; Pavlicich V; Dalziel SR; Payne DC; Malley R; Borland ML; Morrison AK; Bhatt M; Rino PB; Beneyto Ferre I; Eckerle M; Kam AJ; Chong SL; Palumbo L; Kwok MY; Cherry JC; Poonai N; Waseem M; Simon NJ; Freedman SB;
JAMA Netw Open; 2022 Jul; 5(7):e2223253. PubMed ID: 35867061
[TBL] [Abstract][Full Text] [Related]
27. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
[TBL] [Abstract][Full Text] [Related]
28. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 in Female and Male Athletes: Symptoms, Clinical Findings, Outcome, and Prolonged Exercise Intolerance-A Prospective, Observational, Multicenter Cohort Study (CoSmo-S).
Widmann M; Gaidai R; Schubert I; Grummt M; Bensen L; Kerling A; Quermann A; Zacher J; Vollrath S; Bizjak DA; Beckendorf C; Egger F; Hasler E; Mellwig KP; Fütterer C; Wimbauer F; Vogel A; Schoenfeld J; Wüstenfeld JC; Kastner T; Barsch F; Friedmann-Bette B; Bloch W; Meyer T; Mayer F; Wolfarth B; Roecker K; Reinsberger C; Haller B; Niess AM;
Sports Med; 2024 Apr; 54(4):1033-1049. PubMed ID: 38206445
[TBL] [Abstract][Full Text] [Related]
30. Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study.
Nimri R; Rachmiel M; Yackobovitch-Gavan M; Brener A; de Vries L; Fisch Shvalb N; Lazar L; Oren A; Jacobi-Polishook T; Shefer Averbuch N; Tenenbaum A; Mel E; Krepel Volsky S; Mouler M; Demol S; Shalitin S; Bello R; Phillip M; Lebenthal Y
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3264-e3272. PubMed ID: 35524727
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study).
Mutubuki EN; van der Maaden T; Leung KY; Wong A; Tulen AD; de Bruijn S; Haverman L; Knoop H; Franz E; van Hoek AJ; van den Wijngaard CC
BMJ Open; 2022 Jul; 12(7):e062439. PubMed ID: 35777877
[TBL] [Abstract][Full Text] [Related]
32. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.
Sun P; Qie S; Liu Z; Ren J; Li K; Xi J
J Med Virol; 2020 Jun; 92(6):612-617. PubMed ID: 32108351
[TBL] [Abstract][Full Text] [Related]
34. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
Karaarslan F; Demircioğlu Güneri F; Kardeş S
Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and clinical presentation of long COVID in children: a systematic review.
Pellegrino R; Chiappini E; Licari A; Galli L; Marseglia GL
Eur J Pediatr; 2022 Dec; 181(12):3995-4009. PubMed ID: 36107254
[TBL] [Abstract][Full Text] [Related]
36. A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection.
Hawkings MJ; Vaselli NM; Charalampopoulos D; Brierley L; Elliot AJ; Buchan I; Hungerford D
Viruses; 2023 Jul; 15(8):. PubMed ID: 37631968
[TBL] [Abstract][Full Text] [Related]
37. Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales.
Swann OV; Lone NI; Harrison EM; Tomlinson LA; Walker AJ; Seaborne MJ; Pollock L; Farrell J; Hall PS; Seth S; Williams TC; Preston J; Ainsworth JS; Semple FF; Baillie JK; Katikireddi SV; Akbari A; Lyons R; Simpson CR; Semple MG; Goldacre B; Brophy S; Sheikh A; Docherty AB
BMJ Open; 2022 Nov; 12(11):e063271. PubMed ID: 36356998
[TBL] [Abstract][Full Text] [Related]
38. Persistent symptoms after COVID-19 in children and adolescents from Argentina.
Seery V; Raiden S; Penedo JMG; Borda M; Herrera L; Uranga M; Marcó Del Pont M; Chirino C; Erramuspe C; Alvarez LS; Lenoir M; Morales LD; Davenport C; Huespe Auchter S; Monsalvo L; Sastoque L; Gavazzi M; Russo C; Sananez I; Pando MLÁ; Laufer N; Muiños R; Ferrero F; Geffner J; Arruvito L
Int J Infect Dis; 2023 Apr; 129():49-56. PubMed ID: 36736574
[TBL] [Abstract][Full Text] [Related]
39. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis.
Fernandez-de-Las-Peñas C; Notarte KI; Macasaet R; Velasco JV; Catahay JA; Ver AT; Chung W; Valera-Calero JA; Navarro-Santana M
J Infect; 2024 Feb; 88(2):77-88. PubMed ID: 38101521
[TBL] [Abstract][Full Text] [Related]
40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
